Am-EuropharmaCorporation

Company Profile

Country: Cape Verde

Business Type: Trading Company

Mr.sir
Tel: (049) 576-6135 / (049) 576-6352 / (02) 698-7036

Mobile:
Tel:(049) 576-6135 / (049) 576-6352 / (02) 698-7036
Fax:0922-833-0095
Province/state:Muntinlupa
City:Muntinlupa
Street:MD Distripark Alabang Warehouse, Km. 23 West Service Road, Cupang, Muntinlupa
MaxCard:

About us

Welcome To Our Site!
Am-Europharma Corporation is one of the leading and biggest local manufacturers of ethical drugs and pharmaceutical products, both branded and generic, in the Philippines. Just recently, the company has expanded its product lines to include food supplement products.

It was incorporated and registered as a manufacturing laboratory in 1979 by its present owners, mainly to provide high-quality primary healthcare medicines at an affordable cost.

Am-Europharma's thrust is geared towards quality service to the public it serves. As such, equipment and facilities upgrade is constantly pursued to enhance greater productivity. At pace is personnel orientation and training on company procedures and policies for greater efficiency.

These, the company believes, are the key elements in cutting a competitive advantage in the ethical drugs and pharmaceutical manufacturing business.

Keeping in step with the rapid development in the pharmaceutical industry, Am-Europharma Corporation has transferred all its manufacturing activities to its new pharmaceutical plant located in Barangay Saimsim, Calamba, Laguna.

This is an ultramodern manufacturing complex situated in a 3.6 hectare lot with state-of-the art manufacturing, research and development, and quality control facilities.

Support facilities such as massive air handling units, cooling towers, water purification systems have been put in place to ensure utmost compliance to international pharmaceutical manufacturing standards.

This manufacturing complex will provide the evolution of better products portfolio through a comprehensive systems integration, application and operation that can meet not only the pharmaceutical manufacturing global standards, but also create opportunities for expansion and new ventures.